Top Markets
Coin of the day
VentriPoint Diagnostics Ltd. VentriPoint Diagnostics Ltd.

VentriPoint Diagnostics Ltd.

VPT
株式のランク #31084
VentriPoint Diagnostics Ltd. is a medical technology company focused on... VentriPoint Diagnostics Ltd. is a medical technology company focused on developing and commercializing diagnostic tools worldwide. These innovative solutions are designed to monitor individuals afflicted with cardiovascular disease. At the core of their offerings is the Ventripoint Medical System (VMS), an advanced medical imaging platform. The VMS generates precise three-dimensional models of the heart's chambers, providing crucial volumetric and functional measurements. This system is further enhanced by its VMS+ software, which processes echocardiogram and magnetic resonance imaging (MRI) data to construct these 3D models. The VMS+ software ensures highly reproducible and accurate quantification of heart chamber volumes and ejection fraction. Beyond its current flagship system, VentriPoint Diagnostics is actively expanding its portfolio with a suite of specialized applications. These applications target various cardiac conditions and imaging techniques, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and heart complications stemming from Covid-19. Founded in 2004, the company operates from its headquarters in Toronto, Canada.
株価
$0.07706337
時価総額
$14.46M
変化(1日)
0.00%
変化(1年)
-3.33%
CA
取引 VentriPoint Diagnostics Ltd. (VPT)

カテゴリー

VentriPoint Diagnostics Ltd.(VPT)のP/B比率
2026 時点のP/B比率 TTM: 0
VentriPoint Diagnostics Ltd. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
VentriPoint Diagnostics Ltd. の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US